| Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom A Kuri, BM Jacobs, N Vickaryous, J Pakpoor, J Middeldorp, G Giovannoni, ... BMC public health 20, 1-9, 2020 | 142 | 2020 |
| Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells B Ceronie, BM Jacobs, D Baker, N Dubuisson, Z Mao, F Ammoscato, ... Journal of neurology 265, 1199-1209, 2018 | 134 | 2018 |
| Type 2 diabetes as a determinant of Parkinson's disease risk and progression H Chohan, K Senkevich, RK Patel, JP Bestwick, BM Jacobs, ... Movement disorders 36 (6), 1420-1429, 2021 | 130 | 2021 |
| Fibrin (ogen) and neurodegeneration in the progressive multiple sclerosis cortex RL Yates, MM Esiri, J Palace, B Jacobs, R Perera, GC DeLuca Annals of Neurology 82 (2), 259-270, 2017 | 103 | 2017 |
| Systematic review and meta-analysis of the association between Epstein–Barr virus, multiple sclerosis and other risk factors BM Jacobs, G Giovannoni, J Cuzick, R Dobson Multiple sclerosis journal 26 (11), 1281-1297, 2020 | 90 | 2020 |
| BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study BM Jacobs, AJ Noyce, G Giovannoni, R Dobson Neurology: Neuroimmunology & Neuroinflammation 7 (2), e662, 2020 | 86 | 2020 |
| Invited Review: From nose to gut–the role of the microbiome in neurological disease JS Bell, JI Spencer, RL Yates, SA Yee, BM Jacobs, GC DeLuca Neuropathology and applied neurobiology 45 (3), 195-215, 2019 | 85 | 2019 |
| Cladribine: mechanisms and mysteries in multiple sclerosis BM Jacobs, F Ammoscato, G Giovannoni, D Baker, K Schmierer Journal of Neurology, Neurosurgery & Psychiatry 89 (12), 1266-1271, 2018 | 75 | 2018 |
| Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank BM Jacobs, D Belete, J Bestwick, C Blauwendraat, S Bandres-Ciga, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (10), 1046-1054, 2020 | 69 | 2020 |
| Lower lymphocyte count is associated with increased risk of Parkinson's disease MP Jensen, BM Jacobs, R Dobson, S Bandres‐Ciga, C Blauwendraat, ... Annals of neurology 89 (4), 803-812, 2021 | 50 | 2021 |
| Big data, machine learning and artificial intelligence: a neurologist’s guide SD Auger, BM Jacobs, R Dobson, CR Marshall, AJ Noyce Practical Neurology 21 (1), 4-11, 2021 | 49 | 2021 |
| Gene-environment interactions in multiple sclerosis: a UK Biobank study BM Jacobs, AJ Noyce, J Bestwick, D Belete, G Giovannoni, R Dobson Neurology: Neuroimmunology & Neuroinflammation 8 (4), e1007, 2021 | 45 | 2021 |
| Investigation of autosomal genetic sex differences in Parkinson's disease C Blauwendraat, H Iwaki, MB Makarious, S Bandres‐Ciga, HL Leonard, ... Annals of neurology 90 (1), 35-42, 2021 | 42 | 2021 |
| Assessment of risk factors and early presentations of Parkinson disease in primary care in a diverse UK population C Simonet, J Bestwick, M Jitlal, S Waters, A Ben-Joseph, CR Marshall, ... JAMA neurology 79 (4), 359-369, 2022 | 36 | 2022 |
| Reciprocal regulation of two G protein-coupled receptors sensing extracellular concentrations of Ca2+ and H+ WC Wei, B Jacobs, EBE Becker, MD Glitsch Proceedings of the National Academy of Sciences 112 (34), 10738-10743, 2015 | 31 | 2015 |
| Stemming the hype: what can we learn from iPSC models of Parkinson's disease and how can we learn it? BM Jacobs Journal of Parkinson's Disease 4 (1), 15-27, 2014 | 20 | 2014 |
| Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis BM Jacobs, T Taylor, A Awad, D Baker, G Giovanonni, AJ Noyce, ... Brain communications 2 (2), fcaa119, 2020 | 19 | 2020 |
| A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia BM Jacobs Schizophrenia research 168 (1-2), 563-568, 2015 | 18 | 2015 |
| Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis D Baker, BM Jacobs, S Gnanapavan, K Schmierer, G Giovannoni Multiple Sclerosis and Related Disorders 35, 19-25, 2019 | 16 | 2019 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 15 | 2023 |
Ruth DobsonCentre for Preventive Neurology, Wolfson Institute of Population Health, QMULVerified email at qmul.ac.uk
